5 天之前 · The strength of Science and its online journal sites rests with the strengths of its community of authors, who provide cutting-edge research, incisive scientific commentary, and insights on what’s important to the scientific world. To learn more about how to get published in any of our journals, visit our guide for contributors.

4 天之前 · Authoritative, up-to-the-minute news and in-depth features on research advances and science policy, from award-winning science journalists.

4 天之前 · Science is a leading outlet for scientific news, commentary, and cutting-edge research. Through its print and online incarnations, Science reaches an estimated worldwide readership of more than one million.

Science has been at the center of important scientific discovery since its founding in 1880. Today, Science continues to publish the very best in research across the sciences, with articles that consistently rank among the most cited in the world.

4 天之前 · Get Science’s award-winning newsletter with the latest news, commentary, and research, free to your inbox daily.

3 天之前 · The Open Access journal Ultrafast Science, published in association with XIOPM, publishes cutting-edge and emerging topics in ultrafast science with broad interest from scientific communities.

Get Science’s award-winning newsletter with the latest news, commentary, and research, free to your inbox daily.

2025年2月24日 · As for the Science family of journals, we will continue to uphold the highest standards of scientific integrity while publishing groundbreaking research, provocative commentary, and news that is unencumbered by interference. These commitments are crucial for our readers and authors who span the globe.

2025年3月31日 · Get Science’s award-winning newsletter with the latest news, commentary, and research, free to your inbox daily.

2024年12月12日 · But that’s not the only reason Science has named lenacapavir its 2024 Breakthrough of the Year. The off-the-charts success of the drug as PrEP sprang from a basic research advance: a new understanding of the structure and function of HIV’s capsid protein, which lenacapavir targets.